Advisor Group Holdings, Inc. Belite Bio, Inc Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Belite Bio, Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 8 shares of BLTE stock, worth $496. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 8
-0.0%
Holding current value
$496
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLTE
# of Institutions
16Shares Held
79.1KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.1KShares$1.25 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC13.5KShares$835,1720.0% of portfolio
-
Marshall Wace, LLP London, X08.49KShares$526,8950.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.7KShares$416,0030.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.46KShares$401,1010.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.54B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...